Home/Filings/4/0001437749-23-000131
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-23-000131

CIK 0000880242other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 12:48 PM ET

Size

14.0 KB

Accession

0001437749-23-000131

Insider Transaction Report

Form 4
Period: 2022-12-28
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2022-12-28+205,0004,031,500 total
    Exercise: $0.17From: 2022-12-28Exp: 2032-12-28Common stock (205,000 underlying)
Footnotes (2)
  • [F1]This Option was granted to Reporting Person to replace an option previously issued to compensate Reporting Person for services to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price and current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.
  • [F2]Reflects the December 28, 2022, expiration of an option to purchase 410,000 shares.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 12:48 PM ET
Size
14.0 KB